PAYS
Paysign, Inc.
+0.49 (+4.15%)12.31USD287K成交股數695M市值47.4本益比(近四季)6.9股價營收比+48.1%營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 28.3M+48% | 28.0M+51% | 22.8M+49% | 21.6M+51% | 19.1M+45% | 18.6M+36% | 15.3M+23% | 14.3M+30% | 13.2M | 13.7M | 12.4M | 11.0M |
| 營業成本 | 10.4M | 9.8M | 9.6M | 9.4M | 7.3M | 6.9M | 6.8M | 6.7M | 6.3M | 6.5M | 6.1M | 5.4M |
| 毛利 | 17.9M+52% | 18.2M+56% | 13.1M+55% | 12.2M+60% | 11.8M+69% | 11.7M+64% | 8.5M+34% | 7.6M+35% | 6.9M | 7.1M | 6.3M | 5.6M |
| 毛利率 | 63.3% | 65.0% | 57.7% | 56.3% | 61.6% | 62.9% | 55.5% | 52.9% | 52.6% | 52.2% | 51.1% | 50.9% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 8.5M | 8.9M | 9.1M | 8.4M | 8.2M | 7.4M | 6.2M | 6.0M | 5.9M | 5.3M | 4.7M | 5.3M |
| 營業利益 | 7.0M+388% | 6.7M+168% | 1.9M+169% | 1.6M+1159% | 1.4M-656% | 2.5M+294% | 690K+17% | 126K-119% | −258K | 632K | 590K | −647K |
| 營業利益率 | 24.8% | 23.8% | 8.1% | 7.3% | 7.5% | 13.4% | 4.5% | 0.9% | -2.0% | 4.6% | 4.8% | -5.9% |
| 稅後淨利 | 6.8M+387% | 5.4M+110% | 1.4M-5% | 2.2M+218% | 1.4M+349% | 2.6M-54% | 1.4M+31% | 697K-769% | 309K | 5.6M | 1.1M | −104K |
| 淨利率 | 23.9% | 19.4% | 6.0% | 10.3% | 7.3% | 13.9% | 9.4% | 4.9% | 2.3% | 41.1% | 8.9% | -0.9% |
| 稀釋 EPS | 0.11+450% | 0.09+80% | 0.02-33% | 0.04+300% | 0.02+100% | 0.05-50% | 0.03+50% | 0.01 | 0.01 | 0.10 | 0.02 | 0.00 |
| 稀釋股數 | 62.0M | 61.0M | 59.6M | 61.8M | 57.9M | 55.1M | 56.1M | 55.9M | 54.8M | 54.2M | 53.5M | 52.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 176M | 179M | 165M | 119M | 114M | 111M | 111M | 134M | 115M | 109M | 88.0M | 86.0M |
| 應收帳款 | 103M | 94.2M | 72.2M | 49.6M | 41.3M | 52.2M | 32.8M | 25.8M | 35.5M | 16.2M | 7.3M | 7.7M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 317M | 313M | 276M | 210M | 194M | 205M | 167M | 182M | 173M | 147M | 111M | 109M |
| 有息負債 | 3.6M | 4.6M | 6.1M | 6.1M | 6.1M | 7.8M | – | – | – | – | – | – |
| 總負債 | 257M | 258M | 228M | 164M | 152M | 166M | 138M | 155M | 148M | 122M | 93.0M | 92.3M |
| 股東權益 | 60.2M | 55.0M | 48.5M | 45.8M | 42.2M | 39.3M | 28.5M | 26.9M | 25.5M | 24.5M | 18.2M | 16.5M |
| 負債比 | 81.0% | 82.4% | 82.4% | 78.2% | 78.2% | 80.9% | 82.9% | 85.3% | 85.3% | 83.3% | 83.7% | 84.8% |
| 淨現金(現金 − 有息負債) | 173M | 175M | 159M | 112M | 108M | 104M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 18.8M-411% | – | – | – | −6.0M | – | – | 8.2M | – | – | – |
| 資本支出 | – | 266K | – | – | – | 79K | – | – | 51K | – | – | – |
| 自由現金流 | – | 18.5M-403% | – | – | – | −6.1M | – | – | 8.2M | – | – | – |
| 折舊攤銷 | 2.3M | 2.6M | 2.2M | 2.2M | 2.1M | 1.8M | 1.6M | 1.4M | 1.3M | 1.2M | 1.0M | 958K |
| 買回庫藏股 | – | 200K | – | – | – | 376K | – | – | 0.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 66.0% | – | – | – | -32.9% | – | – | 62.1% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 82.5M
| Plasma Industry | 45.6M | 55.3% | +4.0% |
|---|---|---|---|
| Pharma Industry | 33.9M | 41.1% | +167.8% |
| Other Revenue | 2.5M | 3.1% | +36.2% |
| Breakage Revenue | 475K | 0.6% | +95.9% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 82.0M | +40.5% | 7.6M | 9.2% | 0.13 | 51.2M |
| FY2024 | 58.4M | +23.5% | 3.8M | 6.5% | 0.07 | 22.5M |
| FY2023 | 47.3M | +24.3% | 6.5M | 13.7% | 0.12 | 27.4M |
| FY2022 | 38.0M | +29.1% | 1.0M | 2.7% | 0.02 | 25.2M |
| FY2021 | 29.5M | +22.2% | −2.7M | -9.2% | -0.05 | 14.9M |
| FY2020 | 24.1M | -30.4% | −9.1M | -37.9% | -0.19 | 12.4M |
| FY2019 | 34.7M | +48.0% | 7.5M | 21.5% | 0.14 | 16.2M |
| FY2018 | 23.4M | – | 2.6M | 11.0% | 0.05 | 15.7M |